#45 - Aaron Mackey, SVP of AI/Data Science at Lokavant & Jonathan Crowther, Head of Predictive Analytics at Pfizer

Join us on the latest episode! Our Guests: Aaron Mackey, SVP of AI/Data Science at Lokavant & Jonathan Crowther, Head of Predictive Analytics at Pfizer.What you'll get out of this episode:Causal AI Explained: Aaron Mackey from Lokavant and Jonathan Crowther from Pfizer discuss the capabilities of causal AI in differentiating cause and effect in clinical trials.Comparison to Generative AI: The episode breaks down the distinctions between generative AI and causal AI, highlighting the advantages of causal approaches in clinical operations.Impact on Clinical Trial Feasibility: The experts explain how causal AI optimizes trial feasibility assessments, leading to more efficient and effective clinical processes.Forecasting Clinical Trials with AI: Insight into how causal AI improves data-driven decision-making and addresses the limitations of traditional trial forecasts.To learn more about our guests and their companies:Aaron's LinkedIn https://www.linkedin.com/in/aaronmackey/ Jonathan's LinkedIn https://www.linkedin.com/in/crowtherjonathan/ Lokavant LinkedIn https://www.linkedin.com/company/lokavant/ Pfizer LinkedIn https://www.linkedin.com/company/pfizer/ Lokavant Website https://www.lokavant.com/en-us/ Pfizer Website https://www.pfizer.com/Our sponsor for this episode is:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/